Taiwan · Delayed Price · Currency is TWD ICARES Medicus Statistics
Total Valuation
ICARES Medicus has a market cap or net worth of TWD 3.47 billion. The enterprise value is 3.71 billion.
| Market Cap | 3.47B |
| Enterprise Value | 3.71B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Aug 26, 2026 |
Share Statistics
ICARES Medicus has 47.34 million shares outstanding. The number of shares has increased by 0.95% in one year.
| Current Share Class | 47.34M |
| Shares Outstanding | 47.34M |
| Shares Change (YoY) | +0.95% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 24.38% |
| Owned by Institutions (%) | 0.29% |
| Float | 21.65M |
Valuation Ratios
The trailing PE ratio is 37.26.
| PE Ratio | 37.26 |
| Forward PE | n/a |
| PS Ratio | 2.87 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 39.68 |
| EV / Sales | 3.07 |
| EV / EBITDA | 14.47 |
| EV / EBIT | 31.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.40.
| Current Ratio | 2.06 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 3.14 |
| Debt / FCF | -9.80 |
| Interest Coverage | 5.30 |
Financial Efficiency
Return on equity (ROE) is 1.63% and return on invested capital (ROIC) is 1.49%.
| Return on Equity (ROE) | 1.63% |
| Return on Assets (ROA) | 2.38% |
| Return on Invested Capital (ROIC) | 1.49% |
| Return on Capital Employed (ROCE) | 5.03% |
| Weighted Average Cost of Capital (WACC) | 4.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, ICARES Medicus has paid 82.21 million in taxes.
| Income Tax | 82.21M |
| Effective Tax Rate | 72.93% |
Stock Price Statistics
The stock price has decreased by -23.63% in the last 52 weeks. The beta is 0.28, so ICARES Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -23.63% |
| 50-Day Moving Average | 72.35 |
| 200-Day Moving Average | 75.07 |
| Relative Strength Index (RSI) | 52.95 |
| Average Volume (20 Days) | 21,949 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICARES Medicus had revenue of TWD 1.21 billion and earned 93.56 million in profits. Earnings per share was 1.97.
| Revenue | 1.21B |
| Gross Profit | 683.39M |
| Operating Income | 118.01M |
| Pretax Income | 112.72M |
| Net Income | 93.56M |
| EBITDA | 236.15M |
| EBIT | 118.01M |
| Earnings Per Share (EPS) | 1.97 |
Balance Sheet
The company has 663.65 million in cash and 800.77 million in debt, with a net cash position of -137.12 million or -2.90 per share.
| Cash & Cash Equivalents | 663.65M |
| Total Debt | 800.77M |
| Net Cash | -137.12M |
| Net Cash Per Share | -2.90 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 40.32 |
| Working Capital | 908.34M |
Cash Flow
In the last 12 months, operating cash flow was -41.59 million and capital expenditures -40.13 million, giving a free cash flow of -81.72 million.
| Operating Cash Flow | -41.59M |
| Capital Expenditures | -40.13M |
| Depreciation & Amortization | 118.13M |
| Net Borrowing | -54.35M |
| Free Cash Flow | -81.72M |
| FCF Per Share | -1.73 |
Margins
Gross margin is 56.46%, with operating and profit margins of 9.75% and 7.73%.
| Gross Margin | 56.46% |
| Operating Margin | 9.75% |
| Pretax Margin | 9.31% |
| Profit Margin | 7.73% |
| EBITDA Margin | 19.51% |
| EBIT Margin | 9.75% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | 0.77% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 13.81% |
| Buyback Yield | -0.95% |
| Shareholder Yield | -0.54% |
| Earnings Yield | 2.69% |
| FCF Yield | -2.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 22, 2025. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 22, 2025 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |